

TMS is a non-invasive, FDA-cleared treatment that helps “wake up” the parts of the brain involved in mood. It uses gentle magnetic pulses—similar to the strength of an MRI—to stimulate underactive brain areas linked to depression and other conditions. During treatment, a small device rests comfortably on your head while the pulses do their work. There’s no surgery, no anesthesia, and no downtime—most patients relax, watch TV, or listen to music and return to their day right after.
Yes by most insurances. Call us today to discuss your insurance coverage and treatment options.
Most patients find TMS therapy very well tolerated. During treatment, you may feel a tapping or clicking sensation on your scalp where the device is placed. This sensation is usually mild to moderate and often becomes more comfortable as your body adjusts over the first few sessions. Patients are able to relax, or watch TV during treatment.
Not at all! TMS is a much gentler, modern treatment. There’s no anesthesia, no sedation, and no memory loss. You stay awake and comfortable while gentle magnetic pulses target specific areas of the brain—many patients relax, watch TV, or scroll on their phone during treatment. ECT, by contrast, requires anesthesia and induces a controlled seizure. With TMS, you can get right back to your day afterward.
NeuroStar TMS therapy does NOT cause memory loss or problems with concentration. Clinical trials have shown no adverse effects on memory or cognition. The most common side effect is temporary scalp discomfort during treatment, which usually resolves within the first week. Fewer than 5% of patients discontinued treatment due to side effects. There is a very rare risk of seizure, occurring in less than 0.1% of patients.
A typical course of NeuroStar TMS therapy involves sessions five days a week for about 4–6 weeks. Each session lasts approximately 20–30 minutes, and patients can return to normal activities immediately afterward.
Many patients experience long-lasting relief after completing a full NeuroStar TMS treatment course, which typically lasts 4–6 weeks. Results can last months to a year or longer. If symptoms return, some patients may benefit from additional or maintenance treatments, which are decided on an individual basis with their provider.
YES. NeuroStar TMS Therapy is FDA-cleared and has multiple clearances based on extensive clinical evidence. It was first cleared in 2008 for the treatment of Major Depressive Disorder (MDD) in adults who have not achieved satisfactory improvement with antidepressant medications.
Since then, the FDA has expanded NeuroStar’s clearances to include:
These FDA clearances reflect that NeuroStar has met strict regulatory standards for safety and effectiveness in these indications.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.